CD24 and cancer: Using RNA-seq analysis, we have identified SLPI among the top three upregulated genes in the highly tumorigenic CD24+ Mvt1 cell subset [19], and suggests that SLPI may play a role in the more aggressive cancers derived from CD24+ cells.